Clinical trial
Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients…
NCT00402454 · Sociedad Andaluza de Enfermedades Infecciosas, Other · Completed
Key facts
| NCT number | NCT00402454 |
|---|---|
| Title | Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis |
| Official title | Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis |
| Lead sponsor | Sociedad Andaluza de Enfermedades Infecciosas, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | isoniazid, rifampin + isoniazid or rifampin + pyrazinamide |
| Enrollment | 300 |
| Start date | Jan 1, 1994 |
| Completion | Dec 1, 1998 |
| First posted | Nov 22, 2006 |
| Last update posted | Jan 11, 2007 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: